Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/06/2012 | US20120225039 Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same |
09/06/2012 | US20120225024 Mucoadhesive polymers having vitamin b partial structures |
09/06/2012 | US20120225017 Mixed micelles |
09/06/2012 | US20120225012 Composition for hard tissue repair |
09/06/2012 | CA2781379A1 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
09/05/2012 | EP2495314A1 Novel vaccine composition |
09/05/2012 | EP2495248A1 Bridged artificial nucleoside and nucleotide |
09/05/2012 | EP2494993A2 Amino acid lipids and uses thereof |
09/05/2012 | EP2494990A1 Agent for regeneration and/or protection of nerves |
09/05/2012 | EP2494983A1 Stable formulations of GLP-1 |
09/05/2012 | EP2494969A1 Pharmaceutical formulations of HDAC inhibitors |
09/05/2012 | EP2494966A1 Stable composition of rasagiline |
09/05/2012 | EP2494960A1 Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt |
09/05/2012 | EP2494959A1 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
09/05/2012 | EP2494958A1 Amphiphilic Entity Nanoparticles |
09/05/2012 | EP2494957A1 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier |
09/05/2012 | EP2494956A1 Paclitaxel/steroidal complex |
09/05/2012 | EP2494955A2 Stable liquid pharmaceutical composition based on trazodone |
09/05/2012 | EP2494953A1 Cosmetic and external skin preparation, and medical instrument |
09/05/2012 | EP2493913A1 High stability streptavidin mutant proteins |
09/05/2012 | EP2493514A1 Sterilization of biodegradable hydrogels |
09/05/2012 | EP2493510A1 Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides |
09/05/2012 | EP2493509A2 Aqueous composition for topical application, method of preparation, uses and device |
09/05/2012 | EP2493508A2 Transdermal pharmaceutical compositions comprising active agents |
09/05/2012 | EP2493484A2 Gastroretentive oral high dose zinc preparations |
09/05/2012 | EP2493453A1 Use of biocompatible compositions and materials polymerized therefrom for inhibiting angiogenesis |
09/05/2012 | EP2493333A2 Stable thickener formulations |
09/05/2012 | EP2493315A1 Dimethyl sulfoxide (dmso) or dmso and methylsulfonylmethane (msm) formulations to treat infectious diseases |
09/05/2012 | EP2493314A1 Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis |
09/05/2012 | CN1896231B Method for separating tetramer uric acid oxydiazing enzyme |
09/05/2012 | CN1832762B Conjugates of hydroxyalkyl starch and g-csf |
09/05/2012 | CN1747747B Aprotinin and analogs as carriers across the blood-brain barrier |
09/05/2012 | CN1738911B Solid surface for biomolecule delivery and high-throughput assay |
09/05/2012 | CN1738603B Emulsive water-soluble concentrates |
09/05/2012 | CN1639569B Methods and compositions for inducing an immune response |
09/05/2012 | CN1635909B Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
09/05/2012 | CN1514729B Sustained-release analgesic compounds |
09/05/2012 | CN1476325B Active agent delivery systems and methods for protecting and administering active agents |
09/05/2012 | CN102656189A Antibodies against human respiratory syncytial virus (RSV) and methods of use |
09/05/2012 | CN102656134A Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same |
09/05/2012 | CN102656133A Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same |
09/05/2012 | CN102655884A Composition containing polyethylene glycol for shaving |
09/05/2012 | CN102655883A GLP-1 receptor agonist compounds with a modified N-terminus |
09/05/2012 | CN102655882A Improved pseudomonas Exotoxin A with reduced immunogenicity |
09/05/2012 | CN102655879A Vaccine composition |
09/05/2012 | CN102655857A Rapidly soluble solid pharmaceutical preparations containing amphiphilic copolymers based on polyethers in combination with hydrophilic polymers |
09/05/2012 | CN102655854A Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
09/05/2012 | CN102655853A Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
09/05/2012 | CN102655767A Liquid food composition |
09/05/2012 | CN102653664A Patch and patch preparation |
09/05/2012 | CN102653573A Anti-adsorption and long-circulation lipid molecule, preparation method and application thereof in fields of medicines and cosmetics |
09/05/2012 | CN102652836A Targeting drug release anticancer protein or polypeptide polymer prodrug and preparation method thereof |
09/05/2012 | CN102652835A Sustained-release polymer retinoic acid |
09/05/2012 | CN102652834A Preparation method and composite of low-molecular heparin nanopolymer |
09/05/2012 | CN102652833A Gastric targeted drug carrier and preparation method thereof |
09/05/2012 | CN102652819A Fuyankang dispersible tablet and preparation method thereof |
09/05/2012 | CN102652817A Tortoise plastron and turtle plaster |
09/05/2012 | CN102652766A Multi-component salvia miltiorrhiza osmotic pump tablet and preparation method thereof |
09/05/2012 | CN102652763A Traditional Chinese medicine preparation for treating burn and scald and preparation method thereof |
09/05/2012 | CN102652759A Process for preparing pharmaceutical mirabilite oral liquid containing dimethyl silicone oil |
09/05/2012 | CN102652756A Compound lincomycin hydrochloride and artemisinin injection for animals and preparation method thereof |
09/05/2012 | CN102652755A Mannitol sodium chloride injection and preparation method thereof |
09/05/2012 | CN102652753A Veterinary compound diminazene aceturate and artemisinin preparation and preparation technology thereof |
09/05/2012 | CN102652748A Stable elvucitabine pharmaceutical composition and preparation method thereof |
09/05/2012 | CN102652738A Novel medicinal outer wrapper facilitating swallow |
09/05/2012 | CN102652736A Method for preparing soybean isoflavone sustained-release microspheres |
09/05/2012 | CN102652735A Porous silica nano particle loaded with medicaments with slight solubility and preparation method and application of particle |
09/05/2012 | CN102652734A Rabeprazole sodium enterosoluble micro-particles and preparation method thereof |
09/05/2012 | CN102652732A Nano water-soluble emulsion and preparation method thereof |
09/05/2012 | CN102652731A Monoglucoside injection of cycloastragenol and preparation method and application of injection |
09/05/2012 | CN102652730A Ointment base, kuh-seng and green tea ointment and preparation method of ointment |
09/05/2012 | CN102652729A Magnetic nanomaterials and methods for chemoembolisation |
09/05/2012 | CN102335133B Cefaclor lipidosome solid preparation |
09/05/2012 | CN102274191B Pharmaceutical composition erythromycin enteric-coated pellet capsule |
09/05/2012 | CN102266283B Acidic buffering sterilization gel for vagina gynaecologically |
09/05/2012 | CN102178680B Long-acting and high-content Huperzine plaster and preparation method thereof |
09/05/2012 | CN102166197B Racecadotril granules and production process thereof |
09/05/2012 | CN102151286B Hydrotalcite tablet and preparation method thereof |
09/05/2012 | CN102138906B Clonidine hydrochloride sustained release micropill preparation |
09/05/2012 | CN102138897B Composition preparation of lomefloxacin compound and sodium chloride and preparation method thereof |
09/05/2012 | CN102133176B Oxaliplatin micelle preparation, preparation method and application thereof |
09/05/2012 | CN102119924B Monodisperse nano aztreonam liposome preparation and preparation method thereof |
09/05/2012 | CN102085380B Preparation method of nano magnetic particles for detection and treatment of coronary heart diseases |
09/05/2012 | CN102038956B Tumor nucleus target medicinal vector and application thereof in preparing anti-tumor medicament |
09/05/2012 | CN102038744B High-permeability environment-friendly high-efficiency skin disinfectant and preparation method thereof |
09/05/2012 | CN102038663B Carbazole sulfonamide antineoplastic agent capsules and preparation method |
09/05/2012 | CN102018683B Effervescent tablet containing piracetam |
09/05/2012 | CN102008727B Injection-purpose medicine composition for improving stability of ligustrazine medicine injection formulation |
09/05/2012 | CN102000338B Silicon dioxide pellet and preparation method thereof |
09/05/2012 | CN102000050B Nimesulide medicine composition for improving dissolution performance and preparation method thereof |
09/05/2012 | CN101983977B Method for synthesizing polysorbate-80 for injection |
09/05/2012 | CN101972376B Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and preparation method thereof |
09/05/2012 | CN101961315B Ornithine aspartate liposome injection |
09/05/2012 | CN101953780B Cefprozil solid preparation and preparation method thereof |
09/05/2012 | CN101947324B Macromolecule based preparation method of pH-responsive metal-organic coordination polymer |
09/05/2012 | CN101947313B Novel effervescent tablet for treating beriberi and preparation process thereof |
09/05/2012 | CN101942097B Method for preparing glycosyl amide modified polysiloxane |
09/05/2012 | CN101933897B Recombinant human endostatin temperature-sensitive gel composition for injection |
09/05/2012 | CN101928243B Acenaphtho heterocyclic compounds, and cyclodextrin inclusion compounds or conjugates thereof and application thereof in preparing Bcl-2 family protein inhibitors |
09/05/2012 | CN101926984B Preparation method of artificial nano red blood cells |